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2-Alkylquinolone (2AQ) alkaloids are pharmaceutically and
biologically important natural products produced by both bac-
teria and plants, with a wide range of biological effects, includ-
ing antibacterial, cytotoxic, anticholinesterase, and quorum-
sensing signaling activities. These diverse activities and 2AQ
occurrence in vastly different phyla have raisedmuch interest in
the biosynthesis pathways leading to their production. Previous
studies in plants have suggested that type III polyketide syn-
thases (PKSs) might be involved in 2AQ biosynthesis, but this
hypothesis is untested. To this end, we cloned two novel type III
PKSs, alkyldiketide-CoA synthase (ADS) and alkylquinolone
synthase (AQS), from the 2AQ-producingmedicinal plant, Evo-
dia rutaecarpa (Rutaceae). Functional analyses revealed that
collaboration ofADS andAQSproduces 2AQvia condensations
of N-methylanthraniloyl-CoA, a fatty acyl-CoA, with malonyl-
CoA. We show that ADS efficiently catalyzes the decarboxyla-
tive condensation of malonyl-CoA with a fatty acyl-CoA to pro-
duce an alkyldiketide-CoA, whereas AQS specifically catalyzes
the decarboxylative condensation of an alkyldiketide acid with
N-methylanthraniloyl-CoA to generate the 2AQ scaffold via
C–C/C–N bond formations. Remarkably, the ADS and AQS
crystal structures at 1.80 and 2.20 Å resolutions, respectively,
indicated that the unique active-site architecture with Trp-332
and Cys-191 and the novel CoA-binding tunnel with Tyr-215
principally control the substrate and product specificities of
ADS and AQS, respectively. These results provide additional
insights into the catalytic versatility of the type III PKSs and
their functional and evolutionary implications for 2AQ biosyn-
thesis in plants and bacteria.
The 2-alkylquinolones (2AQs)4 comprise a subclass of alka-
loids with a wide range of biological effects, such as antibacte-
rial (1), cytotoxic (1), and anticholinesterase (2) activities, as
well as quorum-sensing signaling (3). Gram-negative bacteria,
Pseudomonas aeruginosa (3), and the medicinal Rutaceae fam-
ily plants,Evodia rutaecarpa (1),Zanthoxylum schinifolium (4),
and Esenbeckia leiocarpa (2), produce 2AQs. In the biosynthe-
sis of 2-heptylquinolinone produced by P. aeruginosa, a previ-
ous study suggested that a -ketoacyl carrier protein synthase
III (FabH)-like enzyme, PqsD, catalyzes the condensation of
anthraniloyl-CoA and malonyl-CoA (1) to produce 2-amino-
benzoyldiketide-CoA (Fig. 1A). Subsequently, the thioesterase
PqsE converts 2-aminobenzoyldiketide-CoA to the corre-
sponding 2-aminobenzoyldiketide acid, which is then accepted
by the FabH-like enzymes, the PqsB and PqsC heterodimeric
enzymes, as the extender substrate with octanoyl-CoA (2) as
the starter substrate to generate 2-heptyl-4-quinolone (5–7). In
contrast, the heterologously expressed type III polyketide syn-
thase 3 (HsPKS3) from the Lycopodiaceae family plant,Huper-
zia serrata, yields 2AQ by catalyzing four reaction steps, con-
sisting of the condensation reaction of 1 and fatty acyl-CoA to
produce alkyldiketide-CoA (AD-CoA), the hydrolysis reaction
of AD-CoA to produce the alkyldiketide acid (AD acid), the
coupling reaction of N-methylanthraniloyl-CoA (3) and AD
acid to produce the linear N-methylanthraniloyldiketide inter-
This work was supported in part by Grants-in-Aid for Scientific Research
from the Ministry of Education, Culture, Sports, Science and Technology,
Japan (JSPS KAKENHI Grants JP15H01836, JP16H06443, JP25242067,
JP26282210, and JP26560435); by Grants-in-Aid for the Cooperative
Research Project from the Institute of Natural Medicine, University of
Toyama, in 2013 (to H. N. and H. M.) and in 2015 (to T. M. andH. M.); and by
the Platform Project for Supporting Drug Discovery and Life Science
Research (Platform for Drug Discovery, Informatics, and Structural Life Sci-
ence) from the Japan Agency for Medical Research and Development
(AMED) (to T. M.). Theauthorsdeclare that theyhavenoconflicts of interest
with the contents of this article.
This article contains supplemental Tables S1–S3.
Thenucleotide sequence(s) reported in this paper hasbeen submitted to theGen-
BankTM/EBI Data Bank with accession number(s) LC208543 and LC208544.
Theatomiccoordinatesandstructure factors (codes5WX3,5WX4,5WX5,5WX6,and
5WX7)havebeendeposited in theProteinDataBank (http://wwpdb.org/).
1 Both authors contributed equally to this work.
2 To whom correspondence may be addressed. Tel.: 81-3-5841-4740; Fax:
81-3-5841-4744; E-mail: abei@mol.f.u-tokyo.ac.jp.
3 To whom correspondence may be addressed. Tel.: 81-76-434-7625; Fax:
81-76-434-5059; E-mail: hmorita@inm.u-toyama.ac.jp.
4 The abbreviations used are: 2AQ, 2-alkylquinolone; AD acid, alkyldiketide
acid; AD-CoA, alkyldiketide-CoA; ADS, alkyldiketide-CoA synthase; AQS,
alkylquinolone synthase; 2ATL, 2-alkyltriketide lactone; CsOLS, C. sativa
olivetol synthase; ClDCS, C. longa diketide-CoA synthase; ClCURS1,
C. longa curcumin synthase 1; QNS, quinolone synthase; CmQNS, C. micro-
carpa quinolone synthase; EtOAc, ethyl acetate; FabH, -ketoacyl carrier
protein synthase IIIs; HsPKS3,H. serrata type III polyketide synthase 3; CHS,
chalcone synthase; MsCHS, M. sativa chalcone synthase; OsCUS, O. sativa
curcuminoid synthase; PKS, polyketide synthase; RdORS, R. dauricum
orcinol synthase; r.m.s.d., rootmean square deviation; RpBAS, R. palma-




J. Biol. Chem. (2017) 292(22) 9117–9135 9117
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc. Published in the U.S.A.
 at Toyam
a U









mediate, and the subsequent C–N bond formation to generate
the 2AQ scaffold in the in vitro enzyme reaction (8). For exam-
ple, HsPKS3 reportedly generated 2-heptyl-N-methyl-4-quin-
olone (4) from the condensation of 2, 3, and 1 via the forma-
tions of octanoyldiketide-CoA (5) and octanoyldiketide acid (6)
(Fig. 1B). However, because there are no reports about the iso-
lation of 2AQs from H. serrata, the 2AQ synthesis by HsPKS3
is predicted to be a non-physiological function of the enzyme
limited to the in vitro enzyme reactions. In contrast, in the
biosynthesis of curcumin in the turmeric Curcuma longa,
feruloyldiketide-CoA is produced by diketide-CoA synthase
(ClDCS), a type III polyketide synthase (PKS), from the conden-
sation of feruloyl-CoA with 1 (Fig. 1C). Subsequently, the feru-
loyldiketide acid, the hydrolyzed product of feruloyldiketide-
CoA, is accepted by the other type III PKS, named curcumin
synthase (ClCURS1), and curcumin is generated from the
decarboxylative condensation of the diketide acid with feru-
loyl-CoA (Fig. 1D) (9). Therefore, it is most likely that two type
III PKSs are involved in the biosynthesis of the 2AQ alkaloids in
E. rutaecarpa, in amanner similar to the curcumin biosynthesis
in turmeric.
Herein, we report two unique type III PKSs from the buds of
E. rutaecarpa, named alkyldiketide-CoA synthase (ADS) and
alkylquinolone synthase (AQS). The functional analyses ofADS
and AQS demonstrated that collaboration of ADS and AQS is
required for the generation of the 2AQ scaffold in E. rutae-
Figure 1. Enzymatic formation of 2AQs and curcuminoids. A, 2-heptyl-4-quinolone formed by PqsB, -C, -D, and -E; B, 2-heptyl-N-methyl-4-quinolone (4)
formed by HsPKS3; C, feruloyldiketide-CoA formed by ClDCS; D, curcumin formed by ClCURS1; E, decanoyldiketide-CoA (21) formed by ADS; F, 2-nonyl-N-
methyl-4-quinolone (17) formed by AQS.
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carpa. Furthermore, our functional analyses indicated that
ADS produced AD-CoA from fatty acyl-CoA and 1 as the sub-
strates, whereas AQS generated 2AQ from 3 andAD acid as the
substrates. Remarkably, unlike the previously reported 2AQ-
producing HsPKS3, both enzymes lacked the ability to catalyze
the one-pot formation of 2AQ by a single enzyme. The X-ray
crystal structures of ADS and AQS and the structure-based
site-directed mutagenesis studies revealed that the substrate
and product specificities of ADS are principally derived from a
unique active-site geometry, whereas those of AQS are attrib-
uted to a novel CoA-binding tunnel architecture.
Results
Sequence analyses of ADS and AQS
Two full-length cDNAs encoding the novel type III PKSs,
ADS and AQS, were cloned from the buds of E. rutaecarpa by
the RT-PCR method. The full-length ADS and AQS cDNAs
contained 1,155- and 1,200-bp open reading frames encoding
Mr 42,705 and 44,065 proteins with 384 and 399 amino acids,
respectively. ADS and AQS shared 76–46% amino acid
sequence identities with other functionally characterized plant
type III PKSs (Fig. 2). ADS shared 62% amino acid sequence
identity with Medicago sativa chalcone synthase (MsCHS),
which produces naringenin chalcone from the condensation of
threemolecules of 1with p-coumaroyl-CoA (7) (10); 61% iden-
tity with AQS; 59% identity with Citrus microcarpa quinolone
synthase (CmQNS), which produces 4-hydroxy-N-methyl-2-
quinolone (8) from the decarboxylative condensation of 1with
N-methylanthraniloyl-CoA (3) (11); 59% identity with Rheum
palmatum benzalacetone synthase (RpBAS), which produces
benzalacetone from the decarboxylative condensation of 1with
7 (12); 54% identity with ClDCS (9); 51% identity with Rhodo-
dendron dauricum orcinol synthase (RdORS), which generates
orcinol from the condensation of three molecules of 1 with
acetyl-CoA (9) (13); 50% identity withHsPKS3 (8); 49% identity
with ClCURS1 (9); and 46% identity withOriza sativa curcumi-
noid synthase (OsCUS), which catalyzes the one-pot formation
of bisdemethoxycurcumin from the condensation of two mol-
ecules of 7 and one molecule of 1 (14). AQS shared 76% amino
acid sequence identity with CmQNS, 61% identity with RpBAS,
60% identity withMsCHS, 56% identity with ClDCS, 53% iden-
tity withClCURS1, 50% identity withOsCUS, 50% identity with
HsPKS3, and 50% identity with RdORS. No additional cDNAs
encoding other type III PKS isomers were obtained in this
study.
ADS and AQS conserved the catalytic triad of type III PKS
(Cys-164, His-303, and Asn-336) and the active-site residues of
CHS (Ser-133, Pro-375, and the “gatekeeper” Phe-215 (MsCHS
numbering)) (Fig. 2). In contrast, Thr-132, Thr-194, Thr-197,
Ser-338, and the gatekeeper Phe-265, lining the active-site cav-
ity of CHS, were uniquely altered with Ser, Met, Cys, Trp, and
Tyr, respectively, in ADS. These residues differ in numerous
functionally distinct type III PKSs and are thought to control
the substrate and product specificities of the enzymes (15, 16).
The substitution of the conservedThr-197 ofCHSwithCyswas
also observed in RpBAS (12). Simultaneous small-to-large sub-
stitutions of Thr-194, Ser-338, and Phe-265 withMet, Trp, and
Tyr were also found in RdORS (13). Interestingly, AQS com-
pletely retained the active-site residues of CmQNS that specif-
ically generate 8 (11). Thus, Thr-132, Met-137, Thr-197, Gly-
256, Phe-265, and Ser-338 in MsCHS were simultaneously
substituted with Met, Ile, Tyr, Ala, Leu, and Gly in AQS. A
phylogenetic tree analysis suggested that ADS and AQS are
grouped in the non-chalcone-producing type III PKSs and are
closest to CmQNS (Fig. 3).
In vitro functional analyses of ADS and AQS by co-incubation
Based on the hypothesis that the two type III PKSs from
E. rutaecarpa generate 2AQ, ADS and AQS were individually
expressed in Escherichia coli M15 as the N-terminally His6-
tagged proteins, and both purified enzymes were subjected to
enzyme reactions. The substrates and the products obtained in
this study are summarized in Fig. 4 and supplemental Table S1.
Because 2AQs were extracted with organic solvents from the
enzyme reactionmixture, the initial functional analyses of ADS
and AQSwere performed for the ethyl acetate (EtOAc)-soluble
portions of the enzyme reaction mixtures, using 3, 1, and
C6–C16 fatty acyl-CoAs (hexanoyl-CoA (10), 2, decanoyl-CoA
(11), lauroyl-CoA (12), myristoyl-CoA (13), and palmitoyl-
CoA (14)) as the substrates (Fig. 5A). The enzyme reaction
products were determined by comparing the retention times
and the UV and MS spectra with those of authentic com-
pounds. The co-incubation of ADS and AQS and the sole incu-
bation of ADS produced 2-methyltriketide lactone (15) and
2-acetylmethyltetraketide lactone (16), derived from three and
four molecules of 1, respectively (Fig. 5,A and B). However, the
co-incubation of ADS and AQS with 3, 1, and the C10 fatty
acyl-CoA 11 generated 2-nonyl-N-methyl-4-quinolone (17),
derived from these three substrates as themajor product, along
with a 2-alkyltriketide lactone (2ATL), 2-nonyltriketide lactone
(18), derived from 11 and two molecules of 1 as the minor
product. The co-incubation of ADS and AQS with 3, 1, and the
C8 fatty acyl-CoA2 also yielded the corresponding 2AQ4 as the
major product, along with 2-heptyltriketide lactone (19) as
theminor product. In contrast, the co-incubationwith 3, 1, and
the C12 fatty acyl-CoA 12 only generated 2-undecyl-N-methyl-
4-quinolone (20). Among the produced 2AQs, 17was predom-
inantly yielded by 21.3% (Fig. 5A). However, no products were
produced by the ADS andAQS co-incubation reactions using 3
and 1 with either 7 or the C6, C14 and C16 fatty acyl-CoAs 10,
13, and 14 as the substrates (Fig. 5A). Furthermore, the co-in-
cubations of CmQNS with ADS or ADS, and the sole incuba-
tion of CmQNS in the presence of 3, 1, and either the C6–C16
fatty acyl-CoAs 10, 2, and 11–13 or 7 as the substrates only
afforded 8 (Fig. 6). Interestingly, the sole incubations of ADS
using 3, 1, and either the C6–C16 fatty acyl-CoAs or 7 as the
substrates revealed that ADS lacks the 2AQ-forming activity;
ADS only afforded the 2ATLs 19 and 18, derived from C8 and
C10 fatty acyl-CoAs 2 and 11 and two molecules of 1, respec-
tively (Fig. 5B). Furthermore, AQS no longer yielded any
products from the sets of the three substrates (Fig. 5C). These
observations clearly suggested that both ADS andAQS lack the
one-pot 2AQ-forming activity, in contrast to HsPKS3, and the
collaboration of ADS and AQS is required for the formation of
2AQ.
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In vitro functional analysis of ADS
To further clarify the catalytic role ofADS in the formation of
2AQ, the substrate and product specificities of ADSwere inves-
tigated by directly subjecting the enzyme reaction mixtures to
HPLC,without extracting the products with EtOAc. TheHPLC
analysis revealed the presence of decanoyldiketide-CoA (21)
and decanoyldiketide acid (22) in the enzyme reactionmixture,
when ADS was incubated with 1 and the C10 fatty acyl-CoA 11
at pH 7.0 (Fig. 7A). The productions of 21 and 22 were not
observed in a control experiment using boiled ADS (Fig. 7A).
However, ADS predominantly afforded 21 at pH 6.5, whereas
the production of 22 was drastically decreased at this pH. Fur-
thermore, the production of 21 was dramatically decreased at
pH 7.5, and instead, that of 22 was remarkably increased, as
compared with those of the reaction at pH 7.0 (Fig. 7A). These
observations suggested that either ADS lacks thioesterase
activity toward 21 or this activity toward 21 was disrupted by
the acidic conditions. To test the thioesterase activity of ADS,
ADS was reacted with the C10 AD-CoA 21 as the substrate at
pH 6.5, 7.0, and 7.5, as the possible assay system. However, the
HPLC analyses did not reveal any differences in the production
of 22 at these different pH values, as comparedwith those in the
control experiment using the boiled ADS (Fig. 7B). These
results strongly suggested that ADS catalyzes the decarboxyla-
tive condensation of 1 with the C10 fatty acyl-CoA 11 to pro-
duce the corresponding AD-CoA 21, whereas the correspond-
Figure 2. Comparisonof theprimary sequences ofADS, AQS, andother type III PKSs. The secondary structures of ADS are delineated as follows:-helices
(rectangles) and-strands (arrows). TheCys, His, andAsn catalytic triad and the residues lining the active-site cavity of CHSare colored red andblue, respectively.
Tyr-215 in AQS and the corresponding residues in other type III PKSs are highlighted in green. GenBankTM accession numbers are as follows: MsCHS, L02902;
CmQNS, AB823730; ClDCS, AB535216; ClCURS1, AB495007; OsCUS, BAC79571; RpBAS, AF326911; RdORS, LC133082. The sequence of HsPKS3 has not yet been
released from GenBankTM.
Figure3. Phylogenetic treeanalysis ofplant type III PKSs. Thebacterial-ketoacyl carrier protein synthase IIIs (KAS III andFABH) from E. coliwere employed
as out groups. The scale represents 0.1 amino acid substitutions per site. ADS and AQS are highlighted with arrows. ACS, acridone synthase; ALS, aloesone
synthase; BAS, benzalacetone synthase; CURS1, curcumin synthase 1; CUS, curcuminoid synthase; DCS, diketide-CoA synthase; OKS, octaketide synthase; OLS,
olivetol synthase;ORS, orcinol synthase; PCS, pentaketide chromone synthase; 2PS, 2-pyrone synthase; STS, stilbene synthase; THNS, tetrahydroxynaphthalene
synthase; VAS, phloroisovalerophenone synthase; VPS, valerophenone synthase. GenBankTM registration numbers are shown in parentheses.
Characterization of two type III polyketide synthases
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Figure 4. Substrates used and products obtained in this study.
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ing AD acid 22 is a by-product generated by the non-enzymatic
hydrolysis of 21, in a manner similar to the productions of
feruloyldiketide-CoA and the corresponding diketide acid, as
observed in the ClDCS enzyme reaction (9).
To evaluate the substrate andproduct specificities ofADS, all
of the ADS-producing AD-CoAs were converted to the corre-
spondingAD acids by the alkaline hydrolysis reaction, and then
the AD-CoA-forming activity of ADS was evaluated by TLC-
based assays, utilizing 2-14C-labeled1 as the extender substrate,
because the UV absorption of the AD acids is quite low (Fig. 8).
The TLC-based assays revealed that ADS accepts the C8 and
C10 fatty acyl-CoAs 2 and 11 as starter substrates, to produce
theAD-CoAs 5 and 21 (6 and 22 in the TLC-based assay) as the
major products, along with the 2ATLs 19 and 18, respectively
(Figs. 8 (B andC) and 9 (A andB)). Furthermore, ADS produced
a trace amount of lauroyldiketide-CoA (23) (lauroyldiketide
acid (24) in the TLC-based assay) as the single product, from
the condensation of 1 with the C12 fatty acyl-CoA 12 (Figs. 8D
and 9C). In contrast, ADS lacked the abilities to accept the C6,
C14, and C16 fatty acyl-CoAs 10, 13, and 14 as the starter sub-
strates as well as 3 and 7 as the starter substrates to produce
starter substrate-derived products (Fig. 8,A andE–H). TheAD-
CoA- and 2ATL-forming activities observed were maximal at
pH 7.5 and pH 6.0, respectively, within the range of pH 5.5–8.0
(Fig. 9).
In the production of AD-CoAs and 2ATLs, 21 (7.0% yield,
according to the yield of 22 at pH 7.5) and 19 (4.6% yield at pH
6.0) were the best products, respectively (Fig. 9). The higher
yield of the AD-CoA over 2ATL and the lack of reports for the
isolation of the 2ATL derivatives from E. rutaecarpa might
indicate that the 2ATLs are by-products limited to the in vitro
enzyme reaction. Interestingly, despite the fact that ADS con-
serves the CHS Thr-194, Ser-338, and Phe-265 with Met, Trp,
andTyr, as in the case of RdORS, our functional analysis of ADS
using 9 and 1 as the substrates did not afford the RdORS-pro-
ducing orcinol; ADS only produced 15 and 16 (Fig. 8I). Thus,
ADS is a novel type III PKS that generates AD-CoA in amanner
similar to that of ClDCS (Fig. 1, C and E).
ClDCS was reported as an allosteric enzyme, due to the sig-
moidal curve in the rate-feruloyl-CoA concentration profile
(9). In contrast, the rate-fatty acyl-CoA concentration profiles
withADS generated a hyperbolic curve, which is a feature of the
Michaelis-Mentenmodel. ADS exhibited aKm value of 12.5M
and a kcat/Km value of 3.84 min1 mM1 for the C10 fatty acyl-
CoA 11, with respect to the 21-forming activity at the pH opti-
mum of 7.5 (Table 1), which are 5.9 and 1.2 times higher than
those of 74.4 M and 3.23 min1 mM1 for the C8 fatty acyl-
CoA 2, respectively. Thus, ADS preferred 11 over 2 as the
starter substrate and efficiently produced 21, as observed in the
functional analysis of ADS described above. The steady-state
kinetic analysis revealed that ADS exhibited a kcat/Km value of
1.65 min1 mM1 for 1, with respect to the 21-forming activity
at the pH optimum of 7.5 (Table 1).
In vitro functional analysis of AQS
Next, we investigated the substrate and product specificities
of AQS, by directly subjecting the enzyme reaction mixtures to
HPLC. In contrast to the other type III PKSs, AQS did not
accept 3, 7, and the C6–C16 fatty acyl-CoAs 10, 2, and 11-14 as
the starter substrates with 1 to generate products (Fig. 6D).
However, the formations of the C8–C12 AD-CoAs 5, 21, and 23
by ADS (Fig. 8) and the C7–C11 2AQs 4, 17, and 20 by ADS and
AQS from 3, 1, and the C8–C12 fatty acyl-CoAs 2, 11, and 12
(Fig. 5A) encouraged us to investigate the AQS reaction prod-
ucts derived from 3 as a starter substrate and the C10 AD-CoA
21 as an extender substrate. As expected, the HPLC analysis
indicated that AQS accepts 21 as the extender substrate with 3,
to produce the corresponding 2AQ 17 (Fig. 10A) via C–C/C–N
bond formations. However, 21 was retained in the AQS and
boiled AQS reactionmixtures at comparable levels. In contrast,
the hydrolyzed product of 21, 22, was obviously consumed in
the AQS reaction (Fig. 10A). This result suggested that AQS
utilizes 22 as the extender substrate but lacks the thioesterase
activity for the formation of 22 from 21. Indeed, AQS accepted
22 as the extender substrate with 3 and provided the C10 2AQ
Figure 5. Enzyme reaction products by co-incubation and sole incuba-
tions of ADS and AQS. Shown are the enzyme reaction products from
N-methylanthraniloyl-CoA (3), malonyl-CoA (1), and fatty acyl-CoAs (hexa-
noyl (10)-, octanoyl (2)-, decanoyl (11)-, lauroyl (12)-,myristoyl (13)-, or palmi-
toyl (14)-CoAs) or p-coumaroyl-CoA (7) by the co-incubation of ADS and AQS
(A), the sole incubation of ADS (B), and the sole incubation of AQS (C).
Characterization of two type III polyketide synthases
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17 with 7.2 times higher efficiency than that from 21 at the
optimum pH 7.5 (Fig. 10A). Quite interestingly, AQSwas capa-
ble of accepting the C6–C16 AD acids (hexanoyldiketide acid
(25), 6, 22, 24, and myristoyl (26)- and palmitoyl (27)-diketide
acids) with 3 to produce the corresponding 2AQs, 2-pentyl-N-
methyl-4-quinolone (28), 4, 17, 20, and 2-tridecyl (29)-, and
2-pentadecyl (30)-N-methyl-4-quinolones, respectively (Fig.
10B). However, AQS lacked the ability to accept 7 as the starter
substrate and did not yield any products (Fig. 10B). These
observations suggested that AQS is a novel type III PKS that
specifically catalyzes the decarboxylative condensation of AD
acid with 3 to generate 2AQ via the C–N bond formation, in a
manner similar to that of ClCURS1 (Fig. 1, D and F).
The steady-state kinetic parameters revealed that theC10AD
acid 22 is the best extender substrate (Table 1) of AQS and
efficiently generates the C10 2AQ 17, in good agreement with
the best production of 17 in the ADS and AQS co-incubation
reactions (Fig. 5A). AQS accepted 3 as the starter substratewith
a Km value of 22.9 M, which is 1.6 times higher than that of
CmQNS (Km 37.8 M (11)) (Table 1).
Overall structures of ADS and AQS
To clarify the structural details of the AD-CoA- and 2AQ-
forming catalytic mechanisms of ADS and AQS, the crystal
structure of ADS complexed with CoASH and the apo-crystal
structure of AQS were solved at 1.80 and 2.20 Å resolutions,
respectively (Fig. 11). The crystallographic data and refinement
Figure6.HPLCelutionprofiles of EtOAc-soluble enzyme reactionproducts by the co-incubationofADS,AQS, andCmQNSandby the sole incubation
of CmQNS and AQS. Shown are enzyme reaction products from N-methylanthraniloyl-CoA (3), malonyl-CoA (1), and fatty acyl-CoAs (hexanoyl-CoA (10),
octanoyl-CoA (2), decanoyl-CoA (11), lauroyl-CoA (12), or myristoyl-CoA (13)) or p-coumaroyl-CoA (7) by the co-incubation of ADS and CmQNS (A), the
co-incubationofAQSandCmQNS (B), and the sole incubationof CmQNS (C).D, enzyme reactionproducts from1 and10,2,11-14,3, or7by the sole incubation
of AQS.
Figure 7. Analysis of all ADS enzyme reaction products. A, the ADS
reaction products from decanoyl-CoA (11) and malonyl-CoA (1) at pH 6.5,
7.0, and 7.5. B, analysis of the thioesterase activity of ADS with
decanoyldiketide-CoA (21) at pH 6.5, 7.0, and 7.5. The HPLC elution pro-
files obtained by ADS and boiled ADS are indicated as black and red lines,
respectively.
Characterization of two type III polyketide synthases
9124 J. Biol. Chem. (2017) 292(22) 9117–9135
 at Toyam
a U









statistics are summarized in supplemental Table S2. The asym-
metric units of ADS and AQS contained four and three mono-
mers, respectively. Significant backbone changes were not
observed between the monomers in the structures of ADS and
AQS, respectively. The structures of ADS and AQS are nearly
identical, with a root-mean-square-deviation (r.m.s.d.) of 1.0 Å
for the C-atoms. The overall structures of ADS and AQS
revealed the typical type III PKS-folds. The catalytic triad (Cys-
157/His-297/Asn-330 in ADS and Cys-170/His-309/Asn-342
in AQS) and the 16-Å-long CoA-binding tunnel are also con-
served in the structures, in locations and orientations very sim-
ilar to those in other plant type III PKSs. The overall structures
of ADS and AQS are highly homologous to those of the struc-
turally characterized plant type III PKSs (r.m.s.d. values of 0.8–
Figure8. Enzyme reactionproducts fromADSand theADSmutant enzymeswith structurally distinct starter substrates.A–H, the TLC-based analysis of
radiolabeled products frommalonyl-CoA (1) and hexanoyl-CoA (10) (A), octanoyl-CoA (2) (B), decanoyl-CoA (11) (C), lauroyl-CoA (12) (D), myristyl-CoA (13) (E),
palmitoyl-CoA (14) (F),N-methylanthraniloyl-CoA (3) (G), and p-coumaroyl-CoA (7) (H) by theADS andADSmutant enzymes. I, HPLC elution profiles of enzyme
reaction products obtained by ADS and the boiled ADS reactions with acetyl-CoA (9) and 1 as the substrates.
Figure 9. pH-dependent AD acid- and 2ATL-forming activities of ADS. Shown are the relative yields of octanoyldiketide acid (6) and 2-heptyltrikeide
lactone (19) frommalonyl-CoA (1) andoctanoyl-CoA (2) (A), decanoyldiketide acid (22) and2-nonyltriketide lactone (18) from1 anddecanoyl-CoA (11) (B), and
lauroyldiketide acid (24) from 1 and lauroyl-CoA (12) (C). The yields of AD acids at pH 6.0–8.0, 2ATL at pH 5.5 and pH 6.0, and 2ATL at pH 6.0–8.0 are indicated
as closed squares and closed and open circles, respectively.
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1.1 and 0.7–1.1Å forADS andAQS, respectively) and exhibited
r.m.s.d. values of 1.0 and 1.0 Å with MsCHS (PDB code 1BI5)
(10), 1.1 and 0.8 Å with RpBAS (PDB code 3A5Q) (17), 0.8 and
0.7 Å with CmQNS (PDB code 3WD8) (11), and 1.1 and 1.1 Å
with ClCURS1 (PDB code 3OV2) (18), respectively.
Active-site structure and structure-basedmutagenesis studies
of ADS
In the absence of the structure of the AD-CoA-producing
type III PKS, such as ClDCS, we compared the active-site struc-
tures of ADS and the aromatic diketide-producing RpBAS.
Most of the active-site residues of ADS and RpBAS, including
the catalytic triad, were superimposable in nearly identical
positions (Fig. 12, A and B). However, the side chains of Trp-
332 andMet-257 inADSprotrudedmore toward the active-site
cavity, as compared with those of Ser-331 and Leu-256 in
RpBAS, respectively. Thus, the side chains of Trp-332 andMet-
257 blocked the access of Cys-191, corresponding to Cys-190 at
the bottomwall in the active-site cavity of RpBAS, to the active-
site cavity of ADS. The substitutions of Ser-332 and Leu-257
withTrp andMet inADS, respectively, thus narrowed and shal-
lowed the active-site cavity of ADS, as compared with that of
RpBAS.
Interestingly, in contrast to the side-chain orientation of the
gatekeeper Phe-258 in RpBAS, the side chain of the corre-
sponding residue, Tyr-259, of ADS protruded toward the oppo-
site side of the active-site cavity. This conformational change is
presumably caused by the simultaneous small to large L209F
and F259Y substitutions in ADS. As a result, the side chain of
Phe-209, neighboring Tyr-259 in ADS, protrudedmore toward
the active-site cavity, as compared with that of Leu-208 of
RpBAS, and restricted part of the active-site cavity of ADS.
Thus, the active-site cavity of ADS, including its entrance, is
much narrower than that of RpBAS, suggesting that the selec-
tive starter substrate specificity for the fatty acyl-CoA of ADS
arises from this characteristic active-site architecture. The total
active-site cavity volume (200 Å3) and the active-site entrance
area (21 Å2) of ADS were apparently smaller than those of
RpBAS (350 and 34 Å2) (Figs. 11 (C andD) and 12 (A and B)). A
docking study predicted that the active-site cavity of ADS is
large enough to accommodate an enzyme-bound monoketide
intermediatewith up to aC10 length (Fig. 11G). Considering the
acceptance of the C8–C12 fatty acyl-CoAs by ADS, the side
chain(s) of one or more residues lining the active-site cavity
might move flexibly and open the gate to a hidden space, to
accept the C12 fatty acyl moiety of the substrate.
On the basis of these observations, we constructed a set of
ADS site-directed mutants, in which Trp-332 was substituted
with Gln, Ile, Val, Ala, and Gly. We also constructed the ADS
C191G/Amutant enzymes, because the corresponding residue
at this position often controls the substrate specificity and the
polyketide-chain elongation reaction in numerous type III
PKSs. Among them, the ADS W332S mutant enzyme formed
inclusion bodies in E. coli, and thus themutant enzymewas not
analyzed in our study. The TLC-based assay revealed that the
ADS W332Q mutant enzyme enhanced the abilities to form
both the C8 AD-CoA 5 (6 in the TLC-based assay) and the C8
2ATL 19, as compared with those of the wild type (Fig. 8B).
Furthermore, the mutant enzyme increased the C10 2ATL 18-
and C12 AD-CoA 23-forming activities (24 in the TLC-based
assay) (Fig. 8, C and D).
Similar results were also obtained in the ADS W332I,
W332V, W332A, andW332G mutant enzyme reactions, using
the C8–C14 fatty acyl-CoAs 2, 11, 12, and 13, respectively, as
the starter substrates. The ADS W332I, W332V, W332A, and
W332G mutant enzymes further enhanced the 19-forming
activity, as compared with that of the ADS W332Q mutant
enzyme, with the loss of the 5-forming activity (6 in the TLC-
based assay) (Fig. 8B). The 18-forming activity was also
enhanced in the ADS W332I, W332V, W332A, and W332G
mutant enzymes, in this order (Fig. 8C). In contrast, the
21-forming activity (the C10 AD acid 22 in the TLC-based
assay) tended to decrease, depending on the substitutions
toward the less bulky residues (Fig. 8C). The 23-forming activ-
ity (the C12 AD acid 24 in the TLC-based assay) was also
decreased with the ADSW332I mutant enzyme, but this muta-
tion conferred the ability to form 2-undecyltriketide lactone
(31) (Fig. 8D). In contrast, the ADS W332V, W332A, and
W332G mutant enzymes lost the 23-forming activity and
afforded 31 as the single product (Fig. 8D). Amazingly, the ADS
W332G mutant enzymes newly accepted the C14 fatty acyl-
CoA 13 as the starter substrate, and generated myris-
toyldiketide-CoA (32) (26 in the TLC-based assay) and 2-tride-
cyltriketide lactone (33) (Fig. 8E). The ADS W332A mutant
enzyme also exhibited the 33-forming activity, although the
activity was significantly decreased, as compared with that of
the ADS W332G mutant enzyme. These observations sug-
gested that the mutant enzymes increased the active-site cavity
volume and thereby enhanced the 2ATL-forming activity.
The crystal structures of the ADS W332Q and W332G
mutant enzymes indeed indicated the expansion of the total
active-site cavity volume, due to the loss of the planar and
bulkier indole ring at this position (Fig. 12, A, C, and D). The
estimated total cavity volumes of the ADS W332Q and
W332G mutant enzymes were 240 and 295 Å3, which are 1.2
and 1.5 times larger, respectively, than that of the wild type
(200 Å3).
Unexpectedly, the ADS W332I, W332V, W332A, and
W332G mutant enzymes newly accepted 3 as the starter sub-
strate with 1 to produce 8 (Fig. 8G). In contrast, none of the
Table 1
Steady-state kinetic parameters of ADS and AQS
Starter substrate Km kcat kcat/Km
M min1 min1 mM1
ADS
2 74.4 0.24 3.23
11 12.5 0.05 3.84
12a NDb ND ND
1 35.8 0.06 1.65
AQS
3 22.9 1.20 51.6
25 9.0 0.01 1.10
6 11.8 0.33 28.0
22 5.0 0.30 60.0
24 9.0 0.49 54.4
26 9.0 0.01 1.44
27 7.1 0.01 1.43
a The kinetic parameters were not detected, due to the trace amount of the prod-
uct. bND, not detected.
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mutant enzymes accepted 7 as the starter substrate to generate
products, as in the case of thewild type (Fig. 8H).We previously
reported that RpBAS accepts not only 7, but also 3, as the
starter substrate to produce 8, because its active-site entrance is
wider than that ofMsCHS (17, 19) (Fig. 11,D and E).Wild-type
ADS had an active-site entrance wider than that of MsCHS but
did not accept 3 as the starter substrate with 1 to yield products
(Figs. 8G and 11 (C and E)). In contrast, our crystal structure
analysis of the ADS W332G mutant enzyme revealed that the
mutant enzyme retains the shallow active-site cavity but
slightly widens the active-site entrance, as compared with
that of the wild type (Figs. 11 (C and F) and 12 (A and D)).
These observations suggested that the ADS W332I, W332V,
W332A, and W332G mutant enzymes allowed the accept-
ance of the bulky N-methylanthraniloyl-CoA starter to the
catalytic center, to yield 8, because of the expansion of the
active-site entrance, whereas none of mutant enzymes
allowed the access of 7 to the catalytic center because of the
shallow active-site cavity.
Next, we investigated the effect of the C191A and C191G
substitutions of ADS on the enzyme activities (Fig. 8). Both
mutant enzymes did not accept 3, 7, and the C6 and C16 fatty
acyl-CoAs10 and14 as the starter substrate (Fig. 8,A andF–H).
However, the ADS C191A mutant enzyme enhanced the abili-
ties for the formations of the C8 and C10 AD-CoAs 5 and 21 (6
and 22 in the TLC-based assay) and the corresponding 2ATLs
19 and 18, respectively, as comparedwith those of thewild type
(Fig. 8, B and C). In addition, the ADS C191A mutant enzyme
also enhanced the C12 AD-CoA 23-forming activity (24 in the
TLC-based assay). Interestingly, the C191G substitution in
ADS further increased the 19- and 18-forming activities, as
compared with those of the ADS C191A mutant enzyme, and
generated 19 and 18 as the major products. Furthermore, the
ADS C191G mutant enzyme conferred the ability to form the
C12 and C14 ATLs 31 and 33 (Fig. 8, D and E). These results
suggested that Cys-191 controls the dynamicmotion of the side
chain of Trp-332, which reflects the AD-CoA-forming activity
of ADS. Thus, Trp-332 and Cys-191 are the crucial residues for
the AD-CoA-forming activity of ADS. Presumably, the side
chain of Trp-332 not only narrows the active-site cavity of ADS,
but also forms putative hydrophobic interactions between the
fatty acyl moiety of the substrate and the active-site cavity. This
would be the reason why ADS exhibited the selective starter
substrate specificity for fatty acyl-CoA.
Active-site structure and structure-basedmutagenesis studies
of AQS
A comparison of the active-site structures of AQS and the
functionallymost similar ClCURS1 revealed that the active-site
cavity of AQS is much wider and shallower than that of
ClCURS1 (Fig. 12, E and F). This is mainly caused by the differ-
ences in the bulkiness of the active-site residues, such as Asp-
198, Met-200, Tyr-203, and Gly-344 in AQS and Glu-192, Thr-
194, Ser-197, and Gln-338 in ClCURS1. The total active-site
Figure 10. Enzyme reaction products fromAQS and the AQS Y215Vmutant enzymewith structurally distinct substrates. A, enzyme reaction products
fromN-methylanthraniloyl-CoA (3) as the starter substrate and decanoyldiketide-CoA (21) or decanoyldiketide acid (22) as the extender substrate by AQS and
the boiled AQS. B and C, enzyme reaction products from 3 andAD acids (hexanoyl (25)-, octanoyl (6)-, decanoyl (22)-, lauroyl- (24), myristoyl (26)-, or palmitoyl
(27)-diketide acid) or p-coumaroyl-CoA (7) by AQS and its boiled enzyme (B) and the AQS Y215V mutant enzyme and its boiled enzyme (C). As the negative
control data, the HPLC elution profiles of the enzyme reaction products from 3 and 22 by the boiled enzyme are shown. D, enzyme reaction products from 3
and malonyl-CoA (1) by AQS, the AQS Y215V mutant enzyme, and CmQNS.
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cavity volume of AQS is 330 Å3, which is larger than that of
ClCURS1 (250 Å3). Thus, the shape and size of the active-site
cavity of AQS restricted the binding of the coumaroyl starter.
Interestingly, the large-to-small Q344G substitution in AQS
also resulted in the expansion of its active-site entrance, as
compared with that of ClCURS1. Furthermore, previous stud-
ies indicated that ClCURS1 prefers a diketide acid lacking a
CoAmoiety as the extender substrate, due to the presence of
the characteristic hydrophobic pocket formed by Gly-211,
Phe-215, Phe-265, and Phe-267 in the CoA-binding tunnel,
located between the protein surface and the catalytic triad
(18). However, the aromatic ring of Tyr-215 in AQS, corre-
sponding to Ala-210 in ClCURS1, occupied the space corre-
sponding to the hydrophobic pocket in ClCURS1 and
resulted in the loss of the hydrophobic cavity from the CoA-
binding tunnel of AQS (Fig. 12, E and F). None of the alter-
native hydrophobic cavities was observed in the CoA-bind-
ing pocket of AQS.
In contrast, the active-site resides of AQSwere sterically well
conserved among those of CmQNS (Fig. 12, E andG). The only
difference between AQS and CmQNS was the protrusion of
Met-138 in AQS, corresponding to Met-132 in CmQNS,
toward Ile-143with a slight displacement of theC atom.Thus,
the active-site cavities of AQS (330 Å3) and CmQNS (290 Å3)
have almost the same size and shape. In contrast, the CoA-
binding tunnel of AQS (470 Å3) was much narrower than that
of CmQNS (650 Å3) (Fig. 12, E and G). Amazingly, this signifi-
cant difference inAQSwas caused by the smaller-to-larger sub-
stitution of Val in CmQNS with Tyr-215 in AQS. The unique
extender substrate specificity of AQS is thus most likely regu-
lated by the CoA-binding tunnel architecture. Remarkably,
HPLC analyses of the reaction products generated by the AQS
Y215V mutant enzyme, using the same substrates as those of
the wild type, only detected the production of a trace amount of
the C10 2AQ 17 (Fig. 10C). In contrast, the mutant enzyme
efficiently generated 8 as the single product, when 3 and 1were
used as the substrates (Fig. 10D). Furthermore, the crystal
structure of the AQS Y215V mutant enzyme clearly indicated
that the Y215V substitution widens the CoA-binding tunnel at
the mutated position, without any conformational changes of
the other residues (Fig. 12,G andH). Thus, the mutant enzyme
possessed an apparently expanded CoA-binding tunnel (575
Å3), similar to that of CmQNS (650 Å3).
These observations strongly suggest that the wide active-
site entrance and the narrow CoA-binding tunnel in AQS
result in the preferences of 3 and AD acid as the starter and
extender substrates, respectively, and thereby specifically
generate 2AQ.
Figure 11.Overall structures of ADS andAQS.A and B, overall structures of ADS (A) andAQS (B). ADS andAQS formhomodimeric structures. Themonomers
are indicated as blue and gray schematic models, respectively. The CoASH molecule is shown as a green stick model. C–F, close-up views of the active-site
entrances of ADS (C), RpBAS (D), MsCHS (E), and the ADS W332G mutant enzyme (F). G, stereo view of the active-site cavity of the docking model of the
ADS-bound decanoyl moiety to the catalytic center Cys. The decanoyl moiety is indicated by a pink stick model.
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Tissue distributions of ADS and AQS gene expression and 2AQ
production
The tissue-specific expressions of ADS and AQS in the
leaves, buds, and fruits of E. rutaecarpawere analyzed by semi-
quantitative RT-PCR, using gene-specific primers. The AQS
gene was expressed at the highest level in leaves, and lesser
amounts were detected in buds and fruits (Fig. 13A). In con-
trast, the ADS gene expressionwas only found in buds, suggest-
ing that ADS could collaborate with AQS in the tissue to pro-
duce the C7–C11 2AQs 4, 17, and 20, as observed in the in vitro
co-incubation assay of the enzymes (Fig. 5A). However, analy-
ses of the contents of the C7–C13 2AQs 4, 17, 20, and 29 in the
buds revealed thatE. rutaecarpa derives 29, as well as 4, 17, and
20, and mostly accumulates 20 (Fig. 13B). This is in contrast to
the results obtained by the in vitro co-incubation assay of ADS
and AQS, in which 17was primarily produced by the enzymes.
Furthermore, these 2AQs accumulated in the fruits and leaves
at higher and lower levels than those in buds, respectively,
despite the lack of ADS gene expression in those tissues. In
addition, E. rutaecarpa reportedly derives the C2, C5, and
C7–C15 2AQs (1). However, ADS andAQSwere only capable of
producing theC8–C12AD-CoAs and theC5–C15 2AQs, respec-
tively. These observations suggest the presence of ADS and
AQS isozymeswith substrate specificities for other alkyl-length
fatty acyl-CoAs in E. rutaecarpa.
Discussion
In this study, we cloned ADS and AQS and performed func-
tional and crystal structure analyses as well as structure-based
site-directed mutagenesis studies. ADS and AQS possess the
unique active-site cavity and the novel CoA-binding tunnel,
respectively, which have never been observed in other type III
PKSs. Trp-332 and Cys-191 in ADS and Tyr-215 in AQS were
indicated to control the substrate and product specificities of
ADS and AQS. Notably, the active-site cavity of ADS is just
large enough to accommodate up to a C10-length enzyme-
bound monoketide intermediate (Fig. 11G). On the basis of
these observations, we propose thatADS catalyzes the fatty acyl
moiety transfer of fatty acyl-CoA to the catalytic center Cys and
the condensation of one molecule of 1 with the enzyme-bound
monoketide intermediate. However, due to the very tight steric
restriction of the active-site cavity, especially fromTrp-332, the
enzyme stops the polyketide elongation reaction at the diketide
stage and releasesAD-CoAas the product, without transferring
Figure 12. Comparisonof the active-site architectures of ADS, AQS, theirmutant enzymes, andother type III PKSs. Shown are surface representationsof
ADS (A), RpBAS (B), the ADS W332Q mutant enzyme (C), the ADS W332G mutant enzyme (D), AQS (E), ClCURS1 (F), CmQNS (G), and the AQS Y215V mutant
enzyme (H). The enzyme residues and the CoASHmolecules are shown as blue and green stick models. The entrances of the CoA-binding tunnels are indicated
with arrows. The catalytic triads and the mutated residues are highlightedwith red and cyan type, respectively.
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the diketide intermediate to the catalytic center Cys. Interest-
ingly, the sequence comparison of ADS and ClDCS revealed
that ClDCS lacks the conserved Ser-338 of the CHS, corre-
sponding to Trp-332 in ADS, and instead has the bulky residue
Gln-337 (Fig. 2), which is likely to restrict part of the active-site
cavity of ClDCS, as in the case of the ADS W332Q mutant
enzyme. However, Met-257, Met-188, Cys-191, and Tyr-259,
lining the bottom wall of the active-site cavity of ADS, are
replaced with the less bulky residues Leu-262, Thr-193, Ser-
196, and Phe-265, respectively, in ClDCS (Fig. 2). Thus, the
active-site cavity of ClDCS is likely to be larger and deeper than
that of ADS, but due to the tight restriction of the active-site
cavity by Gln-337, ClDCS seems to preferentially produce an
aromatic diketide-CoA, as in the case of ADS.
Furthermore, ADS lacked the RdORS-producing orcinol-
forming activity, despite the conservation of the Thr-194, Ser-
338, and Phe-265 of CHS with Met, Trp, and Tyr. A sequence
comparison of ADS and RdORS revealed that Met-257, at the
bottom of the active-site cavity of ADS, is replaced in RdORS
with the less bulky Leu-278, whereas Asn-206, neighboring the
side chain of Tyr-259 in ADS, is substituted with the larger
His-215 in RdORS (Fig. 2). The large-to-small M278L and
small-to-large N215H substitutions in RdORS are likely to
result in the protrusion of the side chain of Tyr-280, corre-
sponding to the gatekeeper Tyr-259 in ADS, toward the active-
site cavity in RdORS. Thus, the active-site cavity of RdORS
might be smaller and shallower than that of ADS, which would
lead to its substrate and product specificities distinct from
those of RdORS.
Conversely, despite the lack of the hydrophobic cavity in the
CoA-binding pocket, AQSpreferred anADacid as the extender
substrate. However, as proposed for the catalytic machinery
with ClCURS1 (18), the hydrophobic interaction between AQS
and an AD acid would be important for the preferential accept-
ance of an AD acid lacking the CoAmoiety. Thus, the aromatic
ring of Tyr-215 could increase the hydrophobicity of the CoA
binding tunnel of AQS, which controls its extender substrate
specificity, in amanner similar to that of ClCURS1. In addition,
Met-138, Met-200, and Tyr-203 in AQS are altered with less
bulky residues, Ser, Thr, and Thr, respectively, in the 2AQ-
producing HsPKS3, whereas Ile-143, Asp-198, and Gly-344 in
AQS are replaced with bulkier residues Met, Glu, and Ser,
respectively, in HsPKS3 (Fig. 2). Leu-271 in AQS, correspond-
ing to the gatekeeper in other type III PKSs, is also substituted
with Phe in HsPKS3. These differences suggest that HsPKS3
possesses a larger, downward expanded active-site cavity than
that of AQS, and the catalytic machinery of HsPKS3 is com-
pletely different from that of AQS. OsCUS, the type III PKS
from O. sativa, also catalyzes the one-pot formation of bisde-
methoxycurcumin from the condensation of 7 and 1 (14) (Fig.
1C).We previously reported that OsCUS could lock both inter-
mediates, the p-coumaroyldiketide acid generated via the
decarboxylative condensation of 1 with 7 and the p-coumaroyl
moiety derived from the second starter substrate 7, in the
active-site cavity (20). Thus, HsPKS3 is most likely to utilize a
catalytic mechanism similar to that of OsCUS.
This comprehensive assessment of the structures and func-
tions of ADS and AQS thus demonstrates that the 2AQs
derived from E. rutaecarpa are generated by two type III PKSs.
However, comparisons of the kcat/Km values of ADS with those
of the functionally most closely related ClDCS and other fatty-
acyl-CoA-accepting type III PKSs, such as C. sativa olivetol
synthase (CsOLS) and RdORS, suggested the low catalytic effi-
cacy of ADS. Thus, the catalytic efficacy of ADS (kcat/Km 1.65
min1 mM1 for 1 with respect to the C10 AD-CoA-forming
activity) is 48 times lower than that of ClDCS (kcat/Km  79.8
min1 mM1 for 1 with respect to the feruloyldiketide-CoA-
forming activities) (9). The catalytic efficacy of ADS (kcat/Km
3.84 min1 mM1 for 11 with respect to the C10 AD-CoA-
forming activity) is 16 and 38 times lower than those of CsOLS
(kcat/Km 60.8min1mM1 for 10with respect to the olivetol-
forming activity) and RdORS (kcat/Km 146.3min1mM1 for
9with respect to the orcinol-forming activity), respectively (13,
21). In contrast, AQS exhibits catalytic efficacy (kcat/Km 51.6
min1 mM1 for 3 with respect to the 17-forming activity)
comparable with that of the functionally most closely related
ClCURS1 (kcat/Km  61.1 min1 mM1 for feruloyl-CoA with
respect to the cinnamoylferuloylmethane-forming activity) (9).
These observations also suggest the presence of ADS isozymes
with different substrate specificities for the other alkyl-length
fatty acyl-CoAs, as described above, but also the same substrate
specificity as that of ADS and with higher catalytic efficacy in
E. rutaecarpa.
Furthermore, our functional analyses suggest that the bio-
synthetic pathway of the plant 2AQ is quite different from that
of the bacterial 2AQs produced byP. aeruginosa, inwhich three
FabH-like enzymes, PqsB, -C, and -D, sharing  19% amino
Figure 13. Analyses of ADS and AQS transcripts and tissue distributions
of 2AQs in E. rutaecarpa. A, semiquantitative RT-PCR analyses of ADS and
AQSgene expression. The 18S rRNAgene fragmentwas amplified as a house-
keepinggene.B, 2AQs contents in leaves, buds, and fruits, analyzedby LC-ESI-
MS. Thedata are presented as themean S.D. (n 3). The yields of theC7, C9,
C11, and C13 2AQs 4, 17, 20, and 29 are represented aswhite, gray, black, and
dotted bars, respectively. The amounts of 2AQswere estimated from thepeak
intensities, by comparison with those of the corresponding authentic 2AQs,
and then converted to the yield percentage against the wet weights of the
tissues, respectively.
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acid sequence similarities with ADS and AQS, and the thioes-
terase PqsE complete the 2AQ biosynthesis in the order of (i)
the condensation of anthraniloyl-CoA and 1 to produce 2-ami-
nobenzoyldiketide-CoA, (ii) the hydrolysis of 2-aminobenzo-
yldiketide-CoA to produce 2-aminobenzoyldiketide acid, and
(iii) the tail-to-tail condensation of 2-aminobenzoyldiketide
acidwith fatty acyl-CoA to generate 2-heptyl-4-quinolone (6, 7)
(Fig. 1A). In contrast, our functional analyses of ADS and AQS
also suggest that fatty acyl-CoA is initially utilized as the sub-
strate with 1, and 3 is finally condensed with an AD acid to
generate 2AQ (Fig. 1, E and F).
In addition, comparisons of the overall structures ofADS and
AQS with those of the bacterial enzymes, PqsB (PDB code
5DWZ) (6), PqsC (PDB code 5DWZ) (6), and PqsD (PDB code
3H76) (22) revealed that all of the enzymes share the thiolase
fold. Thus, the overall structures of PqsB, PqsC, and PqsD
exhibited r.m.s.d. values of 3.2, 2.6, and 2.3 Å for ADS and 3.0,
2.7, and 2.4 Å for AQS, respectively. Furthermore, the Cys-His-
Asn catalytic triad and theCoA-binding tunnel in PqsD are also
well conserved in the structures of ADS and AQS, in locations
andorientations similar to those inADSandAQS.These obser-
vations suggest that ADS, AQS, and PqsD evolved from a com-
mon ancestor. However, Tyr-259 and Trp-332, within the
active-site cavity of ADS, are replaced in PqsD with the less
bulky Phe and Ala. Thus, the active-site cavity of PqsD is larger
than that of ADS, suggesting that PqsD could catalyze the con-
densation of anthraniloyl-CoA with 1 to produce 2-aminoben-
zoyldiketide-CoA (22). In contrast, PqsC in the PqsBC het-
erodimer only conserves theCys andHis of the catalytic triad in
ADS and AQS, whereas PqsB lacks the Cys, His, and Asn, cor-
responding to the catalytic triad residues. Because PqsB and
PqsC share the thiolase fold, as in the case of PqsD, both
enzymes are most likely to have evolved from the common
ancestor of ADS, AQS, and PqsD. However, the PqsBC het-
erodimer possesses a unique large active-site cavity elon-
gated from PqsC to PqsB (6). These features are in sharp
contrast to the active-site architectures and catalytic
machineries of ADS and AQS, suggesting that the PqsBC
heterodimer specifically evolved in P. aeruginosa, and thereby
could confer the ability to generate 2AQs by utilizing a different
biosynthetic pathway from that of E. rutaecarpa. On the basis
of these observations, we propose that the 2AQ biosynthesis
evolved in a parallel but independent manner in E. rutaecarpa
and P. aeruginosa.
In conclusion, our functional analyses of ADS andAQSdem-
onstrated that two novel type III PKSs are involved in the 2AQ
alkaloid biosynthesis in the medicinal plants. Furthermore, the
crystal structure analyses and structure-based site-directed
mutagenesis studies of ADS and AQS suggested that the
unique active-site architecture principally controls the sub-
strate and product specificities of ADS and AQS, respec-
tively. These findings provide insights into not only the cat-
alytic versatility of the type III PKSs and the structural bases
for the catalytic machineries of ADS and AQS, but also the
functional and evolutionary implications for 2AQ biosyn-
thesis in plants and bacteria.
Experimental procedures
Materials
Malonyl-CoA (1) and acetyl-CoA (9) were purchased from
Sigma-Aldrich, and N-methylanthraniloyl-CoA (3), p-couma-
royl-CoA (7), and fatty acyl-CoAs (2 and 10–14) were synthe-
sized as described previously (23). The [2-14C]1 (52.4 mCi/
mmol) was purchased from PerkinElmer Life Sciences.
AD-CoA (21), AD acids (6, 22, and 24–27), and authentic sam-
ples of 2AQs (4,17,20, and28–30) were synthesized according
to the published reports (24–26). Authentic samples of 2ATLs
(15, 18, 19, 31, and 33), 2-acetylmethyltetraketide lactone (16),
and 4-hydroxy-N-methyl-2-quinolone (8) were obtained in our
previous work (11, 27, 28). E. rutaecarpa (Rutaceae) buds,
leaves, and fruits were harvested from the Medical Herb Gar-
den (Faculty of Pharmaceutical Sciences, University of Toyama,
Japan) and immediately frozen in liquid nitrogen.
Cloning of the ADS and AQS cDNAs
Total RNA was extracted from E. rutaecarpa buds with an
RNeasy plant minikit (Qiagen) and was reverse-transcribed
using Superscript II RT (Invitrogen) and the oligo(dT) primer
(5-GACTCGAGTCGACATCGATTTTTTTTTTTTTT-3),
according to the manufacturer’s protocol. The single-stranded
cDNA thus obtained was used as the template for the PCRs
with inosine-containing degenerate oligonucleotide primers,
designed on the basis of the conserved sequences of the known
CHSs (112S, 174S, 368A, and 380A (the primer’s number indi-
cates the amino acid number within M. sativa CHS)), as
described previously (11), and nested PCR was performed with
the primer sets 112S and 380A and thenwith 174S and 368A, to
amplify the respective 555-bp core fragments of E. rutaecarpa
ADS and AQS, using the previously reported conditions (11).
The 5- and 3-RACEs were performed with the SMARTer
RACE cDNA amplification kit (Clontech), using the gene-spe-
cific primers (5-CCATCCTCTGAATCAGGGATTGTTGT-
TTGATTTGC-3 for 5-RACE of ADS, 5-AATGGCTTCAA-
AGGTGGAGAGTCGGCAGGCAGCAG-3 for 3-RACE of
ADS, 5-AAAACAGCTTGCCCATATAATAAATCAACGC-
GGTT-3 for 5-RACE of AQS, and 5-TGCTGGAGCTCGA-
GTTCTTTTAGTGTTTTGTGATC-3 for 3-RACE of AQS).
The full-length cDNA encoding ADS was obtained using the
sense primer 5-GCGGGATCCATGGCTTCAAAGGTGGA-
GAGTCGCA-3 (the BamHI site is underlined) and the anti-
sense primer 5-CGCCTCGAGTCAATTGATAGCAACAC-
TACGGAGGA-3 (theXhoI site is underlined). The full-length
cDNA encoding AQS was obtained using the sense primer 5-
GCGGGATCCATGGCTTCATCTTTTTCAATGGAAAA-3
(the BamHI site is underlined) and the antisense primer
5-CGCCTCGAGATGGTTGGAATCTAGAGGGACAC
TGA-3 (the XhoI site is underlined). The amplified full-length
ADS and AQS cDNA fragments were digested with BamHI/
XhoI and individually cloned into the BamHI/SalI sites of pQE-
80L (Novagen). Both recombinant enzymes thus contained an
additional N-terminal hexahistidine tag, MRGSHHHHHHGS,
before the first residue. The nucleotide sequences were deter-
mined by Eurofin Genomics.
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Amino acid sequence alignment and phylogenetic tree
The amino acid sequences of 31 type III PKSs, three FabH-
like enzymes, and two FabHs were aligned. A phylogenetic tree
was developed with the Clustal Omega version 1.2.1 program
(European Bioinformatics Institute) and was visualized by
Mega version 7.0 (29).
Enzyme expression and purification
The plasmids containing the full-length cDNAs encoding
ADS and AQS were individually transformed into E. coliM15.
The cells harboring the plasmid were cultured to an A600 of 0.6
in LB medium containing 100 g/ml ampicillin at 37 °C, and
isopropyl 1-thio--D-galactopyranoside (1mM forADS, 0.1mM
for AQS) was then added to induce the protein expression. The
culture was incubated further at 27 °C for 16 h. All of the fol-
lowing procedures were performed at 4 °C. The E. coli cells
were harvested by centrifugation at 6,000  g for 20 min and
resuspended in buffer A (50 mM Tris-HCl buffer (pH 8.0), 200
mM NaCl, 5% (v/v) glycerol), containing 10 mM imidazole, 0.5
mg/ml lysozyme, and 0.1 units/ml benzonase nuclease (Merck).
The cells were disrupted by sonication, and the lysate was cen-
trifuged at 8,000  g for 20 min. The supernatant was loaded
onto a HisTrap HP column (GE Healthcare) equilibrated with
buffer A. After the resin was washed with buffer A, the recom-
binant protein was subsequently eluted with buffer A contain-
ing 600 mM imidazole. The protein solution was diluted 5-fold
with buffer B (50 mM Tris-HCl (pH 8.0) and 5% (v/v) glycerol)
and applied to a Resource Q column (GEHealthcare). The pro-
teins were separated with buffer B containing 50–350 mM
NaCl, and the fractions containing ADS (or AQS) were col-
lected and concentrated to 5 ml. The resultant solution was
further purified to homogeneity by gel filtration chromatogra-
phy on a HiLoad 16/60 Superdex 200 column (GE Healthcare),
and the fractions containing ADS (or AQS) were concentrated
to 10 mg/ml in buffer A with a Microcep 10k centrifugation
device (PALL Life Sciences). The protein concentration was
calculated by measuring the UV absorption at A280.
Co-incubation assays of ADS, AQS, andQNS
ADS andAQS,QNS andADS, orQNS andAQS (20g each)
were co-incubated with 55 M 3, 60 M fatty acyl-CoA (10, 2,
11-13, or 14), and 100 M 1, in a final volume of 500 l of 100
mM potassium phosphate buffer (pH 7.5), at 37 °C for 16 h. The
co-incubation assay using 7 as the substrate, instead of fatty
acyl-CoA, was performed under the same reaction conditions
except for the substitution of fatty acyl-CoA with 7. The reac-
tions were stopped by the addition of 20l of 20%HCl, and the
enzyme reaction products were extracted twice with 500 l of
EtOAc. The extracts were then evaporated under reduced pres-
sure, and the residueswere dissolved in 80l of 100%methanol.
An aliquot of the sample (20 l) was injected into an online
LC-ESI-MS system with an Agilent Technologies series 1100
HPLC connected to a Bruker Daltonics Esquire 4000 ion-trap
mass spectrometer fitted with an ESI source. The enzyme reac-
tion products were eluted with a gradient of water and CH3CN,
both containing 0.1% trifluoroacetic acid: 0–5 min, 20%
CH3CN; 5–45min, 20–100%CH3CN, on aTSK-gelODS-80Ts
column (4.6-mm inner diameter  150 mm; Tosoh) at a flow
rate of 0.6 ml/min. The ESI capillary temperature and the cap-
illary voltage were 350 °C and 4.0 V, respectively. The tube lens
offset was set at 20.0 V. All spectra were obtained in the positive
mode over a mass rangem/z of 50–1,200 and at a range of one
scan every 0.2 s. The collision gas was helium, and the relative
collision energy scale was set at 30.0% (1.5 eV).
Analysis of EtOAc-soluble enzyme reaction products
generated by the sole incubations of ADS, AQS, andQNS
All procedures were performed according to the same pro-
cedure used for the co-incubation assays of ADS, AQS, and
QNS, except for using the sole enzymes.
Analysis of all reaction products produced by ADS and the ADS
mutant enzyme
For the detection of the formations of21 and22, ADS (20g)
was incubatedwith 300M 11 and 500M 1 in a final volume of
100 l of 100 mM potassium phosphate buffer (pH 6.5, 7.0, or
7.5) at 37 °C for 14 h. For the assessment of the thioesterase
activity of ADS, 20 g of ADS was incubated with 60 M 21, in
a final volume of 100 l of 100 mM potassium phosphate buffer
(pH 7.5), at 37 °C for 16 h. The reactions were stopped by the
addition of 4 l of 20% HCl and a 20-l aliquot of the enzyme
reaction mixtures was directly injected into an Agilent Tech-
nologies series 1290 HPLC. The enzyme reaction products
were eluted with a gradient of 25 mM potassium phosphate
buffer, pH 6.5, and CH3CN: 0–5 min, 30% CH3CN; 5–21 min,
30–42% CH3CN; 21–26 min, 42–80% CH3CN: 26–40 min,
80% CH3CN, on a TSK-gel octyl-80Ts column (4.6-mm inner
diameter 150 mm; Tosoh) at a flow rate of 0.6 ml/min.
For the TLC-based assays, 4 g of ADS was incubated with
60 M starter substrate (10, 2, 11-14, 3, or 7) and 101.6 M
[2-14C]1 (1.1 mCi/mmol), in a final volume of 100l of 100mM
potassium phosphate buffer (pH 7.5), at 37 °C for 16 h. A 5-l
portion of 20% NaOH was then added, and the reaction was
incubated further at 65 °C for 15min, to hydrolyze theAD-CoA
to the corresponding AD acid. The hydrolysis reaction was
quenched by the addition of 10 l of 20% HCl. The reaction
products were extracted with 100 l of EtOAc and separated
with a hexane/EtOAc/acetic acid solvent system (9:1:1, v/v/v)
on analytical TLC plates (Merck silica gel 60 F254). Radioactiv-
ities were quantified by autoradiography, using a Typhoon
FLA-9500 biomolecular imager (GE Healthcare). The radioac-
tive compounds on the TLC plates were analyzed with the
ImageQuant TL software (GE Healthcare). The total enzyme
reaction products produced by the mutant enzymes were also
analyzed with the TLC assay, according to the same procedure
used for the wild type ADS. The optimumpH values of ADS for
the formation of 2ATL and AD-CoA were also analyzed with
the TLC assays, using the same procedure as described above,
except for the use of 100 mM MES-NaOH buffer (pH 5.5–6.0)
and 100 mM potassium phosphate buffer (pH 6.0–8.0).
Analysis of ORS activity of ADS
ADS (20g) was co-incubated with 60M 9 and 100M 1, in
a final volume of 500 l of 100 mM potassium phosphate buffer
(pH 7.5), at 37 °C for 16 h. The reaction was stopped, and the
enzyme reaction products were extracted with EtOAc and ana-
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lyzed by LC-MS, according to the same procedure used for the
co-incubation assays of ADS, AQS, and QNS.
Analysis of all reaction products produced by AQS and the AQS
mutant enzyme
For the determination of the type of extender substrate of
AQS, 20 g of AQS was incubated with 55 M 3 and either 60
M 21 or the correspondingADacid 22, in a final volume of 100
l of 100 mM potassium phosphate buffer (pH 7.5), at 37 °C for
16 h. The reactions were stopped, and the products were ana-
lyzed by HPLC, using the same methods as for the assessment
of the thioesterase activity of ADS.
For the identification of the 2AQ-forming activity of AQS
with different alkyl chain lengths of the extender substrates,
AQS (20g) was incubatedwith 55M 3 and 60MAD acid (6,
22, 24–26, or 27), in a final volume of 100 l of 100 mM potas-
sium phosphate buffer (pH 7.5), at 37 °C for 16 h. The optimum
pH value of AQS for the formation of 2AQwas evaluated using
100 mM potassium phosphate buffer (pH 6.0–8.0). The reac-
tion products were analyzed according to the same procedure
used for the determination of the type of extender substrate of
AQS, except for the use of 25 mM potassium phosphate buffer
(pH 6.5) and a CH3CN gradient system: 0–5min, 15% CH3CN;
5–21 min, 15–42% CH3CN; 21–26 min, 42–80% CH3CN;
26–40 min, 80% CH3CN. The reactions of the AQS mutant
enzymes and the analysis of the products generated by the
mutant enzymes were performed according to the same proce-
dure used for the wild type AQS.
Analysis of all reaction products by the sole incubations of
AQS, the AQSmutant enzyme, or CmQNS
AQS, the AQSY215mutant enzyme, or CmQNS (20g) was
incubated with 55 M 3 and 100 M 1, in a final volume of 100
l of 100 mM potassium phosphate buffer (pH 7.5), at 37 °C for
16 h. The reactions were stopped, and the products were ana-
lyzed by HPLC, using the same methods as for the co-incuba-
tion assays of ADS, AQS, and CmQNS.
Kinetics of ADS and AQS
Steady-state kinetic parameters of ADS were determined
using [2-14C]1 as the extender substrate. All experiments were
performed in triplicate for each reaction condition.
For the kinetic values of ADS toward fatty acyl-CoAs (2, 11,
and 12), the enzyme reaction mixture contained 4 g of ADS,
101.6 M [2-14C]1 (1.1 mCi/mmol), and five concentrations of
fatty acyl-CoA (32, 16, 8, 4, 2 M), in a final volume of 100 l of
100 mM potassium phosphate buffer (pH 7.5). For the kinetic
value of ADS toward 1, the reactionmixtures contained 4g of
ADS, 60 M 11, and five concentrations of [2-14C]1 (260, 130,
65, 32.5, and 16.25M containing 2.88, 1.44, 0.72, 0.36, and 0.18
mCi/mmol, respectively), in a final volume of 100 l of 100 mM
potassium phosphate buffer (pH 7.5). The mixtures were incu-
bated at 37 °C for 20 min, and the enzyme reaction products
were quantified using the same procedures as for the TLC-
based assays of ADS reaction products.
For the steady-state kinetic parameters of AQS toward AD
acids (6, 22, 24–27), the reaction mixture contained 4 g of
AQS, 55M 3, and five concentrations (32, 16, 8, 4, and 2M) of
AD acid in a final volume of 100 l of 100 mM potassium phos-
phate buffer (pH 7.5). For the steady-state kinetic parameters of
AQS toward3, the reactionmixture contained 4g ofAQS, 180
M 22, and five concentrations (64, 32, 16, 8, 4M) of 3 in a final
volume of 100 l of 100 mM potassium phosphate buffer (pH
7.5). These mixtures were incubated at 30 °C for 20 min and
extractedwith 100l of EtOAc, and the EtOAc-soluble enzyme
reaction products were analyzed by using the same proce-
dure as for the identification of the 2AQ-forming activity of
AQS against the alkyl chain length of the extender substrate.
Lineweaver-Burk plots of all data were generated to derive
the apparent Km and kcat values, using the Excel program
(Microsoft).
Site-directedmutagenesis of ADS and AQS
The plasmids expressing the ADS and AQSmutant enzymes
were constructed with a QuikChange site-directed mutagene-
sis kit (Stratagene), according to the manufacturer’s protocol,
using the ADS and AQS expression plasmids as templates and
primers listed in supplemental Table S3. The mutant enzymes
were expressed and purified with the same procedures as
described for the wild-type enzymes and used for the enzyme
assays and crystallizations.
Crystallizations and structure determinations of ADS, AQS,
and their mutant enzymes
All crystallization attemptswere performedusing the sitting-
drop vapor diffusion technique at 20 °C. Diffraction quality
crystals of ADS, itsW332QandW332Gmutant enzymes, AQS,
and its Y215V mutant enzyme were obtained in the optimized
reservoir conditions listed in supplemental Table S2 after initial
screenings using 96-condition crystallization screening kits
(Qiagen; originally designed byMitsubishi Chemical Corp.). All
crystallization drops were prepared by mixing 0.5 l of either
the purified ADS (10 mg/ml, containing 5 mM CoASH), ADS
W332Q mutant (5 mg/ml, containing 10 mM CoASH), ADS
W332Gmutant (5mg/ml, containing 10mMCoASH), AQS (22
mg/ml), or AQS Y215V mutant (10 mg/ml) protein solutions
and an equal volume of reservoir solution and equilibrating the
mixtures against 50 l of reservoir solution. The crystals of the
wild-type ADS were transferred into a crystallization solution
containing 12% (v/v) ethylene glycol as a cryoprotectant. The
crystals of the ADSW332Q andGmutant enzymes were trans-
ferred into a crystallization solution containing 10 mM CoASH
and 12% (v/v) ethylene glycol as a cryoprotectant. The crystals
of the wild-type AQS and AQS Y215V mutant enzymes were
transferred into a crystallization solution containing 20% (v/v)
glycerol as a cryoprotectant. After a few seconds, the crystals
were picked up in a nylon loop and then flash-cooled to
173 °C in a nitrogen gas stream. X-ray diffraction data sets
were collected on the beamlines NW-12A for the crystals of the
ADSwild type complexedwithCoASHandAQSwild-type apo,
BL17A for the crystals of the ADSW332Gmutant enzyme, and
NE-3A for the crystals of theAQSY215Vmutant enzyme at the
Photon Factory (Tsukuba, Japan), and BL41XU for the crystals
of the ADSW332Qmutant enzyme complexed with CoASH at
SPring-8 (Hyogo, Japan). Diffraction data of the crystals were
processed and scaled with XDS (30). Molecular replacements
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were performed with the C. microcarpa acridone synthase
(PDB code 3WD7) and CmQNS (PDB code 3WD8) structures
as the search models, using Molrep (31) and Phaser (32), to
solve the ADS and AQS wild-type structures, respectively. The
ADS W332Q, ADS W332G, and AQS Y215V mutant enzyme
structures were solved by the molecular replacement method
with the ADS and AQSwild-type structures (PDB codes 5WX3
and 5WX4, respectively) as the search models, respectively,
using Phaser (32). The structure refinements of ADS com-
plexed with CoASH, the ADS W332Q mutant enzyme
complexed with CoASH, the ADSW332Gmutant enzyme com-
plexed with CoASH, and the AQS Y215Vmutant enzyme were
performed using phenix.refine (33), with the twin operators (h,
k, hl), (h, k, hl), (h, k, hl), and (h, k, l) at
0.04, 0.04, 0.03, and 0.03, respectively. The structure refine-
ment of AQS apo was performed using phenix.refine (33). The
structures were modified manually with COOT (34) and
refined with phenix.refine (33). The quality of the final models
was assessed with Molprobity (35). The structure-based simi-
larity was searched with the Dali program (36). The active-site
cavity volumes and entrance areas were calculated with the
CASTp program. All crystallographic figures were prepared
with PyMOL.
Dockingmodel of ADS complexedwith the substrate
The three-dimensional structure of the Cys-tethered de-
canoylmonoketide was generated by the CHEM3D ULTRA 10
program (Cambridge Soft), and its geometry was optimized
using the elbow tool in PHENIX (37). The intermediate model
was manually swapped with the catalytic Cys-157 in the ADS
structure with COOT (34), and then the energy minimization
calculation by simulated annealing with the CNS program (38)
was performed. The parameters of the intermediate for the
energy minimization calculation were obtained with the PRO-
DRG server (39).
Analyses of ADS and AQS gene expression by semiquantitative
RT-PCR
Total RNA from E. rutaecarpa buds, leaves, and fruits was
isolated as described above. The first-strand cDNA was then
synthesized from 50 ng of each RNA sample, using SuperScript
IV (Invitrogen) with a random hexamer (Invitrogen) as the
primer. The ADS (678 bp) and AQS (720 bp) gene fragments
were amplified with the primer pairs ADS_q and AQS_q,
respectively (supplemental Table S3). The 18S rRNA gene
(GenBankTM accession number AB699582, 610 bp) was ampli-
fied with the primer pair 18S (supplemental Table S3) and was
loaded on the 2% agarose gel as the PCR product control. All
genes were amplified with PrimeSTAR HS DNA polymerase
(TaKaRa). The amplified DNA fragments were stained by
ethidiumbromide and visualizedwith the ImageQuantTL soft-
ware (GE Healthcare).
Tissue distributions of C7, C9, C11, and C13 2AQs
Methanol extracts (100 mg/ml) were prepared from the
buds, leaves, and fruits ofE. rutaecarpa, and theC7, C9, C11, and
C13 2AQs contents were analyzed by LC-ESI-MS, under the
conditions described under “Co-incubation assays of ADS,
AQS, and QNS.” The 2AQs in the extracts were determined by
comparing the retention times and theUV andMS spectrawith
those of authentic compounds.
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